Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Background The main advantage of GeneXpert MTB/RIF ® (Xpert) molecular diagnostic technology is the rapid detection of M .tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of th...

Full description

Saved in:

Bibliographic Details
Published in:	BMC infectious diseases Vol. 20; no. 1; pp. 1 - 9
Main Authors:	Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Format:	Journal Article
Language:	English
Published:	London BioMed Central 25.07.2020 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Clinical outcomes Diagnosis Diagnostic systems Disease transmission Drug resistance GeneXpert MTB/RIF Health services HIV Human immunodeficiency virus Imprisonment Infectious Diseases Internal Medicine Medical Microbiology Medical research Medicine Medicine & Public Health Mutation Parasitology Patient outcomes Patients Rank tests Research Article Rifampicin Rifampin Statistical analysis Survival analysis Tropical Medicine Tuberculosis Tuberculosis and other mycobacterial diseases Russia Drug resistance Rifampicin GeneXpert MTB/RIF
ISSN:	1471-2334, 1471-2334
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!